| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.165 | 16.895 | - | 26.261 | 17.605 | 11.447 | 21.024 | 23.064 | 33.809 | 36.959 |
| Total Income - EUR | 12.165 | 16.895 | - | 27.349 | 17.605 | 11.447 | 21.024 | 23.064 | 33.809 | 36.959 |
| Total Expenses - EUR | 10.999 | 15.646 | - | 25.992 | 16.994 | 8.353 | 16.586 | 18.558 | 32.502 | 36.455 |
| Gross Profit/Loss - EUR | 1.166 | 1.249 | - | 1.357 | 611 | 3.094 | 4.438 | 4.507 | 1.308 | 504 |
| Net Profit/Loss - EUR | 804 | 742 | - | 536 | 83 | 2.751 | 3.883 | 3.828 | 1.098 | 430 |
| Employees | 1 | 1 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Agc Medtech Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.991 | 4.132 | - | 0 | 0 | 0 | 0 | 0 | 4.008 | 3.549 |
| Current Assets | 1.259 | 1.644 | - | 10.259 | 10.138 | 10.391 | 14.724 | 19.059 | 18.478 | 9.544 |
| Inventories | 0 | 0 | - | 124 | 437 | 1.888 | 3.377 | 3.714 | 1.374 | 1.420 |
| Receivables | 193 | 283 | - | 4.255 | 3.330 | 5.432 | 5.334 | 5.328 | 9.901 | 958 |
| Cash | 1.066 | 1.361 | - | 5.879 | 6.371 | 3.070 | 6.013 | 10.017 | 7.203 | 7.166 |
| Shareholders Funds | 3.311 | 4.019 | - | 7.484 | 7.422 | 10.033 | 13.693 | 17.564 | 18.609 | 18.796 |
| Social Capital | 45 | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.939 | 1.756 | - | 2.611 | 1.991 | 358 | 1.030 | 1.495 | 3.876 | 4.349 |
| Income in Advance | 0 | 0 | - | 164 | 725 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4520 - 4520" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Agc Medtech Srl